Singh et al. (20) have identified stem-like cells lacking the expression of neural differentiation markers in pediatric brain tumors that express CD133, and showed that CD133+ human GBM cells can initiate tumor formation in the brains of immunodeficient mice (21). This evidence concerns the gene PROM1 and brain neoplasm.